- Residual Vascular Risk Reduction: The Global Call to Action
- Announcement of the Launch of the Residual Risk Reduction Initiative: R3i
—
NEW ORLEANS, Louisiana, November 7NEW ORLEANS, Louisiana, November 7 /PRNewswire/ -- KEY FACTS:
Residual Risk Reduction Initiative (R3i) calls for action to reduce the lipid related residual vascular risk unaddressed by current standards of care in millions of patients with heart disease and diabetes
WHERE:
Audubon Room, Ritz Carlton Hotel, 921 Canal Street, New Orleans, USA
WHEN:
Sunday 9 November 2008, 19:00-20:30 hrs CST (GMT- 6hrs)
WHAT:
Internationally recognized specialists from North America, Europe, Asia and Japan come together to launch the Residual Risk Reduction Initiative (R3i) - a unique global program to evaluate and to reduce the excess risk of myocardial infarction, stroke, kidney disease, loss of vision and non-traumatic limb amputation which exists in many patients with heart disease and diabetes despite optimal, currently available care.
To address these important issues, the R3i engages healthcare professionals in an innovative global initiative of academic research, education and advocacy.
WHO:
Professor Frank Sacks, Vice-President R3i, Department of Nutrition Harvard School of Public Medicine, Boston, MA, USA
Professor W.Virgil Brown, International Steering Committee R3i, Charles Howard Candler Professor of Medicine, Emory University, Chief of Medicine, Atlanta, GA, USA
Professor Michel Hermans, General Secretary R3i, Department of Endocrinology and Nutrition, Cliniques Universitaires St. Luc, Université Catholique de Louvain, Brussels, Belgium
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
